Zugman, M., Ebrahimi, H., Barragan-Carrillo, R., Dizman, N., Jaime-Casas, S., Li, X., Hsu, J., Castro, D. V., Egelston, C. A., Lee, P. P., Guzman, M., Synold, T. W., Takahashi, M., Hayashi, A., Parks, T. P., Caporaso, G., Lee, K., Dorff, T. B., Pal, S. K., Chehrazi-Raffle, A. (2026). First results of a dose-escalation study evaluating
                    <i>Clostridium butyricum</i>
                    MIYAIRI 588 (CBM588) with nivolumab/ipilimumab (nivo/ipi) in metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.503